Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
3
×
boston
boston blog main
life sciences
national blog main
boston top stories
clinical trials
national top stories
new york blog main
san francisco blog main
akero therapeutics
aligos therapeutics
apellis pharmaceuticals
aragon pharmaceuticals
astellas pharma
atlas venture
audentes therapeutics
avidity biosciences
baker brothers life sciences
benzodiazepine
biotech ipos
blackstone group
blepharitis
bluebird bio
cavion
cephalgia
chronic hepatitis b virus
corey goodman
david goldstein
demodex blepharitis
depression
duchenne muscular dystrophy
dyne therapeutics
epilepsy
essential tremor
eventide asset management
facioscapulohumeral muscular dystrophy
fda
financing
funding
What
biotechs
3
×
ipos
medicines
ago
approach
bags
capital
central
cns
considering
data
diseases
disorder
drug
drugs
dyne
early
emerged
expected
experimental
eyes
genetic
having
humans
investing
investors
ipo
kept
leads
led
limited
long
making
medicine
mitigated
muscle
nervous
new
partners
praxis
Language
unset
3
×
Current search:
biotech
×
biotechs
×
unset
×
@xconomy.com
3 years ago
Praxis Precision Medicines Leads Way as Three More Biotechs Prep IPOs
@xconomy.com
3 years ago
Dyne Eyes IPO for R&D of Genetic Medicines for Rare Muscle Diseases
@xconomy.com
4 years ago
VenBio Partners Bags $394M to Back More Medicine-Making Biotechs